new_0222_0598|FREQ|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0598|FREQ|1|Frequency Therapeutics Inc Total Current Assets (Quarterly) (USD)|Frequency Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Frequency Therapeutics Inc Inventories (Quarterly) (USD)|Frequency Therapeutics Inc Net PP&E (Quarterly) (USD)|Frequency Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Frequency Therapeutics Inc Total Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Deposits (Quarterly) (USD)|Frequency Therapeutics Inc Book Value (Quarterly) (USD)|Frequency Therapeutics Inc Retained Earnings (Quarterly) (USD)|Frequency Therapeutics Inc Treasury Stock (Quarterly) (USD)|Frequency Therapeutics Inc EV to Revenues|Frequency Therapeutics Inc EV to Earnings|Frequency Therapeutics Inc EV to Free Cash Flow|Frequency Therapeutics Inc EV to Assets (Quarterly)|Frequency Therapeutics Inc PS Ratio|Frequency Therapeutics Inc PE Ratio|Frequency Therapeutics Inc Price to Book Value|Frequency Therapeutics Inc PEG Ratio|Frequency Therapeutics Inc Debt to Equity Ratio|Frequency Therapeutics Inc Dividend Yield|Frequency Therapeutics Inc Shareholder Yield (TTM)|Frequency Therapeutics Inc Percent of Shares Outstanding Short|Frequency Therapeutics Inc Total Receivables (Quarterly) (USD)|Frequency Therapeutics Inc Total Payables (Quarterly) (USD)|Frequency Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Frequency Therapeutics Inc Return on Invested Capital|Frequency Therapeutics Inc Quality Ratio Score|Frequency Therapeutics Inc Momentum Score|Frequency Therapeutics Inc Beta (1Y)|Frequency Therapeutics Inc Sustainable Growth Rate (TTM)|Frequency Therapeutics Inc Institutional Investor Ownership Percentage|Frequency Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Frequency Therapeutics Inc Total Employees (Annual)|Frequency Therapeutics Inc EPS Diluted (Quarterly) (USD)|Frequency Therapeutics Inc SG&A Expense (Quarterly) (USD)|Frequency Therapeutics Inc Shares Outstanding|Frequency Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Frequency Therapeutics Inc Ordinary Shares Number (Quarterly)|Frequency Therapeutics Inc Payout Ratio|Frequency Therapeutics Inc Quick Ratio (Quarterly)|Frequency Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Frequency Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Frequency Therapeutics Inc Effective Tax Rate (TTM)|Frequency Therapeutics Inc Return on Equity|Frequency Therapeutics Inc Net Income (TTM) (USD)|Frequency Therapeutics Inc Revenue (TTM) (USD)|Frequency Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Frequency Therapeutics Inc Revenue (Quarterly) (USD)|Frequency Therapeutics Inc Gross Profit (Quarterly) (USD)|Frequency Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Frequency Therapeutics Inc Net Income (Quarterly) (USD)|Frequency Therapeutics Inc Net Interest Income (Quarterly) (USD)|Frequency Therapeutics Inc Price (USD)|Frequency Therapeutics Inc Total Return Price (USD)|Frequency Therapeutics Inc Enterprise Value (USD)|Frequency Therapeutics Inc 30-Day Average Daily Volume|Frequency Therapeutics Inc 1 Year Price Returns (Daily)|Frequency Therapeutics Inc Short Interest|Frequency Therapeutics Inc PE Ratio (Forward)|Frequency Therapeutics Inc PE Ratio (Forward 1y)|Frequency Therapeutics Inc PS Ratio (Forward)|Frequency Therapeutics Inc PS Ratio (Forward 1y)|Frequency Therapeutics Inc Quarterly EPS Estimates (USD)|Frequency Therapeutics Inc Quarterly Revenue Estimates (USD)|Frequency Therapeutics Inc Quarterly EPS Surprise|Frequency Therapeutics Inc Quarterly Revenue Surprise|Frequency Therapeutics Inc Quarterly Actual EPS (USD)|Frequency Therapeutics Inc Quarterly Actual Revenue (USD)|Frequency Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Frequency Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Frequency Therapeutics Inc Price Target (USD)|Frequency Therapeutics Inc Consensus Recommendation|Frequency Therapeutics Inc Price Target Num Estimates|Frequency Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Frequency Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Frequency Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Frequency Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Frequency Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Frequency Therapeutics Inc Land and Improvements (Quarterly) (USD)|Frequency Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Frequency Therapeutics Inc Other Properties (Quarterly) (USD)|Frequency Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0598|FREQ|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0598|FREQ|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0598|FREQ|5|100.4|100.4||100.4||100.4|100.4|100.4||100.4|100.4||1.44444444444|91.4|1.44712430427|91.2857142857|1.44444444444||1.44712430427|1.43827160494|91.2857142857|1.44833333333|91.25|15.2545454545|104.428571429|100.4|100.4|91.25||32.8461538462|30.4666666667|91.25||91.3333333333|244|91.3333333333|91.3333333333|38.35||100.4|91.25|91.2857142857|91.3333333333|91.4|91.2857142857|91.25|91.4444444444|91.25||91.2857142857||91.3333333333|91.3333333333|91.3333333333|1.44833333333|1.44833333333|1.44833333333|1.45008756567|1.44380403458|15.2545454545|||1.44712430427|1.44712430427|91.2727272727|91.3333333333|91.2857142857|91.2857142857|91.2857142857|91.2857142857|17.3617021277|37.0909090909|21.4736842105|12.75|21.4736842105|33.7083333333|36.7727272727|91.3333333333|91.3333333333|91.3333333333|||100.4|100.4||
new_0222_0598|FREQ|6|10|10||10||10|10|10||10|10||414|5|539|7|414||539|162|7|600|4|55|7|10|10|4||13|15|4||12|2|12|12|20||10|4|7|12|10|7|4|9|4||7||12|12|12|600|600|600|571|347|55|||539|539|11|12|7|7|7|7|47|22|38|64|38|24|22|12|12|12|||10|10||
new_0222_0598|FREQ|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0598|FREQ|201809||||||||||||||||||||||||||||||||||18.1164||-0.2835|1.507||||||-0.2826|||||||||-5.136|-5.136|-0.063||||||||||||||||||||||||3.55|0.149|0.063||||||
new_0222_0598|FREQ|201812|42.937|42.189||1.511||92.83|3.773|89.057||-48.282|-49.088||||||||||||||0.161|1.863|0.002|||||||18.1164||-0.3007|2.404|||30.7793|||-0.2945|||||||||-5.447|-5.447|-0.011||||||||||||||||||||||||2.921|0.21||||1.109|0.216||
new_0222_0598|FREQ|201903||||||||||||||||||||||||||||||||||18.1164||-0.3216|2.47||||||-0.3211|-0.076||||||||-5.826|-5.826|0.099||||||||||||||||||||||||3.446|0.167|||||||
new_0222_0598|FREQ|201906|32.832|31.509||1.625||5.145|4.88|0.265||29.859|-61.766||||||||||||||0.374|2.223|0.019|||||||30.7793|37|-0.2226|3.098|||30.7793|||-0.2242|-0.088|||-23.261|||||-6.852|-6.852|0.119||||||||||||||||||||||||3.921|0.207||||1.605|0.225||
new_0222_0598|FREQ|201909|166.721|165.321||1.566||167.8|72.204|95.596||-59.652|-63.355|||||||||||||2.2001|0.408|19.574|62.703|||||||30.7793||-0.0516|20.269|30.7849||30.7793||2.2953|-0.0204|0.164|||-18.7|||24.238||-0.575|-0.575|0.624|14.4|14.4|340.6826|90555.8333||677312|||||||||||26.6667|28.8073|27.5|1.6667|2|0.1511|-1.1889|5.221|0.214||||1.689|0.252|16.7|
new_0222_0598|FREQ|201912|221.355|217.355||1.762||55.86|52.78|3.08||167.358|-68.888||||9.7535|1.4486|||3.2308|||||6.4969|0.805|1.219|0.031|||||||30.8445|47|-0.19|5.001|30.8445||30.8445||4.1334|-0.1917|-80.062|||-18.746|||4.709||-5.493|-5.493|0.942|17.53|17.53|323.3491|143787.8||2003929|||15.2785|17.8297|0.13|12.5705|-246.1538|-62.5393|-0.19|4.709|32.6057|||1.6667||-0.4539||5.746|0.225||||1.846|0.257|23.91|21.66
new_0222_0598|FREQ|202003|209.941|206.113||3.977||50.872|43.728|7.144||164.849|-73.801||||11.5176|1.6047|||3.3502|||||7.6652|0.246|2.676|0.031|||||||30.8682||-0.16|6.249|31.0092||31.0093||4.7192|-0.1617||-0.2135||-17.833|||7.264||-4.875|-4.913|0.71|17.81|17.81|346.1609|104578.5||2376924|||15.6055|18.2112|-0.255|5.86|-55.1373|23.959|-0.3956|7.264|23.3733|62.2567|29.5|1.6667|2|-1.0314|-0.1567|6.552|0.215||||4.065|0.494|15.91|18.56
new_0222_0598|FREQ|202006|198.424|195.379||4.553||43.085|41.165|1.92||161.701|-79.826||11.874|-31.2344|22.7142|2.5938|16.0546||4.4932||||-10.9969|13.5738||2.448|0.031|-13.6881||||-18.3209||31.0667||-0.19|5.959|31.2495||31.2495||4.7462|-0.1901||-0.2653|-18.3209|-17.006|44.734||8.523||-6.018|-6.025|0.178|23.25|23.25|531.1719|398679.4667||4241746|||20.53|23.958|-0.2475|6.145|23.2261|38.6981|-0.19|8.523|24.7893|61.3897|29.5|2|2|-0.61|-0.3195|8.764|0.244||||4.766|0.499|21.14|19.34
new_0222_0598|FREQ|202009|227.343|224.231||5.162||34.728|32.919|1.809||199.592|-85.167||13.3499|-19.4638|-6.751|1.8085|19.0407||3.2466||||-18.5502|12.4715||4.101|0.034|-15.6285||9|0.2995|-17.1745|87.9101|33.0739||-0.16|6.512|33.7323||33.7323||6.8116|-0.1604|-40.143|-0.2763|-17.1745|-21.772|31.743||11.247||-5.326|-5.341|0.074|19.21|19.21|423.7665|193923.1|58.5507|4206936|||18.3103|21.3677|-0.3151|5.8807|49.2289|91.2511|-0.16|11.247|27.555|63.1275|32.3333|1.75|3|-1.3169|-1.8|9.948|0.301||||5.019|0.561|21.88|28.7
new_0222_0598|FREQ|202012|225.064|220.341||37.838||72.231|26.634|45.597||192.491|-95.399||26.8286|-37.4271|-19.1332|3.7482|30.7068||6.2214||0.0779||-3.7316|13.6573|0.34|5.586|0.034|-14.7121||9|0.68|-14.9612||33.8238|87|-0.3|8.399|33.964||33.964||8.2857|-0.2996|-1.545|-0.1322|-14.9612|-26.511|36.984||9.95||-10.257|-10.232|0.032|35.26|35.26|992.2296|286791.5667|101.1409|4638572|||39.4899|82.5911|-0.3263|8.3494|8.0713|19.1702|-0.3|9.95|35.3898|66.3058|47|1.6|4|-0.9175|-1.2907|11.542|0.386||||34.717|0.574|38.99|49.21
new_0222_0598|FREQ|202103|200.077|194.909||39.611||64.104|18.918|45.186||177.407|-115.774||4.2229|-3.4581|-2.1292|0.601|9.1266||1.8322||0.0846||-13.7479|23.2528||5.745|0.034|-22.6626||8|-0.5855|-23.4214||34.1157||-0.6|9.744|34.2162||34.2162||10.3028|-0.6005||0.0071|-23.4214|-41.973|34.371||4.651||-20.375|-20.375|-0.193|9.5|9.5|145.1449|1843643.6333|-46.6592|7956233|||10.7187|22.4175|-0.3|8.1267|-100|-42.7687|-0.6|4.651|42.6097|73.875|19.75|1.8|4|-1.3|-0.6207|14.826|0.382|0.218|||36.828|0.577|11.61|8.85
new_0222_0598|FREQ|202106|172.364|168.889||39.389||54.173|9.031|45.142||166.04|-133.43||5.3479|-3.5183|-2.4598|0.8564|9.5499||2.0627|-0.0377|0.0903||-13.0482|15.8988||4.017|0.034|-28.4453||1|0.3674|-29.8719||34.2384||-0.52|9.499|34.3859||34.3859||18.701|-0.5198|||-29.8719|-53.604|35.265||9.417||-17.646|-17.656|-0.064|9.96|9.96|188.5946|530607.9|-57.1613|5466957|||11.2934|23.6196|-0.5265|6.7086|1.2364|40.3721|-0.52|9.417|49.781|13.875|14.25|1.8|4|-2.5891|-2.7996|17.401|0.921|0.182|||38.562|3.511|8.33|7.72
new_0222_0598|FREQ|202109|149.909|148.074||38.153||55.069|10.485|44.584||147.116|-158.585||3.1437|-2.0682|-1.381|0.5034|6.8381||1.6581|-0.0267||||13.4221||3.85|0.035|||1|1.1458|||34.4487||-0.73|9.328|34.5519||34.5519|||-0.7297||0.0163||-73.418|||||-25.152|-25.155|-0.01|7.06|7.06|110.8624|198033.3667|-63.2483|4637571|||8.0438|16.8232|-0.7724|3.964|5.4943|-100|-0.73||48.7872|14.5|12.75|2|4|-2.7341|-2.8746|15.214|0.735|0.182|||38.028|3.511|6.28|5.1
new_0222_0598|FREQ|202112|||||||||||||1.2601||-0.5535||4.9688||1.2066|-0.0194||||10.3631||||||1|-0.3463||||||||||||||||||||||||5.13|5.13|44.4358|230096.7333|-85.4509|3585866|||15.3026|4.4157|-0.7254|38.75|||||45.0736|11.6|13.25|2|4|-2.5721|-2.2098||||||||5.37|3.85
new_0222_0598|FREQ|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.61|1.25||||||||||||||||||||
new_0222_0598|FREQ|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.7|||||||||||||||||||||
new_0222_0598|FREQ|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.54|3.25||||||||||||||||||||
new_0222_0598|FREQ|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||12.5||||||||||||||||||||